Tag: NASDAQ

shareholders-will-probably-not-have-any-issues-with-crinetics-pharmaceuticals-incs-nasdaqcrnx-ceo-compensation

Shareholders Will Probably Not Have Any Issues With Crinetics Pharmaceuticals, Inc.’s (NASDAQ:CRNX) CEO Compensation

Investors Beware: CEO Compensation at Crinetics Pharmaceuticals Under Scrutiny Ahead of AGMKey Insights: • Crinetics Pharmaceuticals to hold Annual General Meeting on 7th of June •...
blackbaud-evp-trades-260m-in-company-stock-blackbaud-nasdaqblkb

Blackbaud EVP Trades $2.60M In Company Stock – Blackbaud (NASDAQ:BLKB)

Blackbaud Executive Vice President Sells $2.60 Million Worth of Company StockOn May 30, David Benjamin, the Executive Vice President at Blackbaud (NASDAQ: BLKB), made...
swiss-national-bank-sells-28800-shares-of-summit-therapeutics-inc-nasdaqsmmt

Swiss National Bank Sells 28,800 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)

Swiss National Bank Sells 28,800 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)Swiss National Bank recently decreased its position in Summit Therapeutics Inc. (NASDAQ:SMMT) by 9.5%...